Showing results (191-200 of 5,917) with videos related to

Sort By:
Pageof 592
Arthritis Research & Therapy|April 30, 2003
The VH gene repertoire of splenic B cells and somatic hypermutation in systemic lupus erythematosusNicola L W Fraser, Gary Rowley, Max Field, et al.
Arthritis Research & Therapy|November 14, 2019
Population-specific factors associated with fractional excretion of uric acidRavi K Narang, Zoe Vincent, Amanda Phipps-Green, et al.
Arthritis Research & Therapy|November 14, 2019
Effective treatment of TNFα inhibitors in Chinese patients with Blau syndromeJing Chen, Yi Luo, Mengzhu Zhao, et al.
Arthritis Research & Therapy|November 16, 2019
Predictors of good response to conventional synthetic DMARDs in early seronegative rheumatoid arthritis: data from the ESPOIR cohortCédric Lukas, Julia Mary, Michel Debandt, et al.
Arthritis Research & Therapy|November 8, 2019
Serum lysophosphatidylcholines to phosphatidylcholines ratio is associated with symptomatic responders to symptomatic drugs in knee osteoarthritis patientsGuangju Zhai, Jean-Pierre Pelletier, Ming Liu, et al.
Arthritis Research & Therapy|November 8, 2019
Inhibition of spinal bone formation in AS: 10 years after comparing adalimumab to OASISDésirée van der Heijde, Robert Landewé
Arthritis Research & Therapy|February 1, 2019
Psychometric validation of the EuroQoL 5-dimension (EQ-5D) questionnaire in patients with spondyloarthritisHelen Hoi Lun Tsang, Jason Pui Yin Cheung, Carlos King Ho Wong, et al.
Arthritis Research & Therapy|January 31, 2019
Reduction of autophagy and increase in apoptosis correlates with a favorable clinical outcome in patients with rheumatoid arthritis treated with anti-TNF drugsM Vomero, V Manganelli, C Barbati, et al.
Arthritis Research & Therapy|January 31, 2019
Reversible SAHH inhibitor protects against glomerulonephritis in lupus-prone mice by downregulating renal α-actinin-4 expression and stabilizing integrin-cytoskeleton linkageShijun He, Xing Liu, Zemin Lin, et al.
Arthritis Research & Therapy|January 31, 2019
Ixekizumab and complete resolution of enthesitis and dactylitis: integrated analysis of two phase 3 randomized trials in psoriatic arthritisDafna D Gladman, Ana-Maria Orbai, Uta Klitz, et al.
Pageof 592